MedTrace Logo

Accelerated Mortality on Renal Replacement

NCT00505180 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10018

Last updated 2007-07-23

No results posted yet for this study

Summary

The purpose of this study is to prospectively identify blood markers that identify chronic hemodialysis patients at risk for early (\<90 days) and late (\>= 1 year) mortality

Conditions

Sponsors & Collaborators

Principal Investigators

  • Ravi I Thadhani, MD, MPH · Massachusetts General Hospital

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Completion
2006-06-30

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00505180 on ClinicalTrials.gov